Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Esprico
- Development stage
- Unknown
- Lead developer
- Engelhard Arzneimittel
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Esprico is a dietary supplement developed by Engelhard Arzneimittel, specifically formulated to support concentration and attention in children, particularly those with Attention Deficit Hyperactivity Disorder (ADHD) or similar behavioral conditions. It contains a balanced combination of omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid), omega-6 fatty acids (gamma-linolenic acid), magnesium, and zinc. These components are essential for brain function and neural development, serving as structural elements of neuronal membranes and cofactors for neurotransmitter synthesis and signaling. The product is marketed as a dietary food for special medical purposes (balanced diet) in Germany and other European markets, intended to address the nutritional requirements associated with impaired concentration and hyperactivity.
- Brand names
- Esprico
- Other names
- Esprico
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on Esprico.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Esprico.